Reevaluation of ACEA 1021 as an antagonist at the strychnine- insensitive glycine site of the N-methyl-D-aspartate receptor

Neuropharmacology

Volumn 37, Issue 6, 1998, Pages 729-737

  Lingenhöhl, Kurt ^a   Pozza, Mario F ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

AMPA receptors; Electrophysiology; Licostinel; Microiontophoresis; Neocortical slice; Rat; Slices

Indexed keywords

6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; ACETYLCHOLINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTICONVULSIVE AGENT; GLUTAMATE RECEPTOR; GLYCINE; KAINIC ACID; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROPROTECTIVE AGENT; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; BRAIN SLICE; CONTROLLED STUDY; DEPOLARIZATION; DOSE RESPONSE; EPILEPTIC DISCHARGE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEOCORTEX; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ELECTROPHYSIOLOGY; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; NEOCORTEX; QUINOXALINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031838981     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00062-8     Document Type: Article

References (24)

1. Collingridge, G.L., Watkins, J.C., 1994. The NMDA Receptor. Oxford University Press, Oxford.
2. Collingridge G.L., Kehl S.J., McLennan H. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334:1983;33-46.
3. Coan E.J., Collingridge G.L. Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci. Lett. 53:1985;21-26.
4. Herron C.E., Lester R.A., Coan E.J., Collingridge G.L. Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism. Nature. 322:1986;265-268.
5. Johnson J.W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurones. Nature. 325:1987;529-531.
6. Kemp J.A., Leeson P.D. The glycine site of the NMDA receptor - five years on. Trends Pharmacol. Sci. 14:1993;20-25.
7. Kemp J.A., Foster A.C., Leeson P.D., Priestley T., Tridgett R., Iversen L.L., Woodruff G.N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the NMDA receptor complex. Proc. Natl. Acad. Sci. USA. 85:1988;6547-6550.
8. Kulagowski J.J., Baker R., Curtis N.R., Leeson P.D., Mawer I.M., Moseley A.M., Ridgill M.P., Rowley M., Stansfield I., Foster A.C., Grimwood S., Hill R.G., Kemp J.A., Marshall G.R., Saywell K.L., Tricklebank M.D. 3′(Arylmethyl)- and 3′(aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: orally active antagonists of the glycine site on the NMDA receptor. J. Med. Chem. 37:1994;1402-1405.
9. Leeson P.D., Iversen L.L. The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J. Med. Chem. 37:1994;4053-4067.
10. Lutfy K., Keana J.F.W., Weber E. Antinociceptive effects of antagonists of the glycine modulatory site associated with the N-methyl-D-aspartate (NMDA) receptor. Soc. Neurosci. Abstr. 19:1993;472.
11. Marek P., Eilon G., Keana J.F.W., Weber E. The neuroprotective effect of three novel NMDA receptor glycine site antagonists in a rat model of focal cerebral ischemia. Soc. Neurosci. Abstr. 20:1994;184.
12. Martin H., Warner D.S., Todd M.M. Effects of glycine receptor antagonism on spreading depression in the rat. Neurosci. Lett. 180:1994;285-289.
13. Matsumoto R.R., Nguyen D., Truong D.D. Strychnine-insensitive glycine site antagonists attenuate a cardiac arrest-induced movement disorder. Eur. J. Pharmacol. 275:1995;117-123.
14. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
15. Pozza M.F., Olpe H.-R., Brugger F., Fagg G.E. Electrophysiological characterization of a novel potent and orally active NMDA-receptor antagonist: CGP 37849 and its ethylester CGP 39551. Eur. J. Pharmacol. 182:1990;91-100.
16. Sheardown M.J., Suzdak P.D., Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur. J. Pharmacol. 236(6):1993;347-353.
17. Singh L., Donald A.E., Foster A.C., Hutson P.H., Iversen L.L., Iversen S.D., Kemp J.A., Leeson P.D., Marshall G.R., Oles R.J., Priestley T., Thorn L., Tricklebank M.D., Vass C.A., Williams B.J. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Proc. Natl. Acad. Sci. USA. 87:1990;347-351.
18. Tsuchida E., Bullock R. The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA 1021 on ischemic brain damage caused by acute subdural haematoma in the rat. J. Neurotrauma. 12:1995;279-288.
19. Warner D.S., Martin H., Ludwig P., McAllister A., Keana J.F., Weber E. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J. Cereb. Blood Flow Metab. 15:1995;188-196.
20. Waynforth, H.B., Flecknell, P.A., 1994. Experimental and Surgical Technique in the Rat. Academic Press, San Diego.
21. Woodward R.M., Huettner J.E., Guastella J., Weber E. In vitro pharmacological characterization of ACEA 1021: a potent NMDA receptor glycine site antagonist. Soc. Neurosci. Abstr. 19:1993;718.
22. Woodward R.M., Huettner J.E., Guastella J., Keana J.F.W., Weber E. In vitro pharmacology of ACEA-1021 and ACEA-1031: Systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol. Pharmacol. 47:1995;568-581.
23. Woodward R.M., Huettner J.E., Tran M., Guastella J., Keana J.F.W., Weber E. Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: A novel systemically active ionotropic glutamate receptor antagonist. J. Pharmacol. Exp. Ther. 275:1995;1209-1218.
24. Xue, D., Miyazaki, B.K., Estrada, J., Woodward, R.M, 1997. ACEA 1021 prevents CA1 neuronal death in a rat model of forebrain ischemia. Soc. Neurosci. Abstr. 23: 2436 (946.19).